Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 860,469 | 596,049 | 511,502 | 581,692 | 512,919 |
| Cost of Goods | 508,065 | 283,396 | 312,202 | 299,138 | 254,624 |
| Gross Profit | 352,404 | 312,653 | 199,300 | 282,554 | 258,295 |
| Operating Expenses | 282,901 | 224,233 | 205,889 | 199,700 | 159,308 |
| Operating Income | 69,568 | 88,816 | -6,387 | 82,992 | 99,611 |
| Interest Expense | 26,226 | 43 | 419 | 632 | 157 |
| Other Income | 16,026 | 1,786 | 153,746 | 951 | -1,343 |
| Pre-tax Income | 59,368 | 90,559 | 146,940 | 83,311 | 98,111 |
| Income Tax | 20,371 | 33,206 | 45,681 | 27,438 | 32,616 |
| Net Income Continuous | 38,997 | 57,353 | 101,259 | 55,873 | 65,495 |
| Net Income | $38,997 | $57,353 | $101,259 | $55,873 | $65,495 |
| EPS Basic Total Ops | 0.56 | 0.84 | 1.51 | 0.85 | 1.02 |
| EPS Basic Continuous Ops | 0.56 | 0.84 | 1.51 | 0.85 | 1.02 |
| EPS Diluted Total Ops | 0.54 | 0.81 | 1.47 | 0.82 | 0.97 |
| EPS Diluted Continuous Ops | 0.54 | 0.81 | 1.47 | 0.82 | 0.97 |
| EBITDA(a) | $138,205 | $122,842 | $29,619 | $172,595 | $118,432 |